Treatment of brain metastases of lung cancer with high doses of etoposide (VP16–213). Cooperative study from the groupe français pneumo-cancérologie
- 1 February 1988
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 24 (2) , 131-135
- https://doi.org/10.1016/0277-5379(88)90243-x
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Penetration of VP 16-213 into cerebrospinal fluid after high-dose intravenous administration.Journal of Clinical Oncology, 1984
- HIGH-DOSE ETOPOSIDE FOR REFRACTORY MALIGNANCIES - A PHASE-I STUDY1984
- High-dose VP-16-213 and autologous bone marrow transplantation for refractory malignancies: a phase I study.Journal of Clinical Oncology, 1983
- VP-16-213 (etoposide): The mandrake root from Issyk-KulThe American Journal of Medicine, 1982
- Etoposide (VP-16-213)Cancer Treatment Reviews, 1979